Made in BC HIV/AIDS Treatment as Prevention®(TasP®) model applied to addictions pilot project

Leave a Comment / By /

“BC Centre for Excellence in HIV/AIDS and Vancouver Coastal Health bring twenty teams together to improve access to suboxone and methadone and treatment.

Read the full story

Leave a Reply

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025

Start typing and press enter to search